Precision medicine takes into account individual genetic variables, physical environment, demographics, social determinants and lifestyle choices to create new methods of disease prevention, early detection and treatment.
“Precision medicine research endeavors must go beyond biologic and clinical markers and include social determinants of health, such as the economic, social and political conditions that influence health status,” said Eliseo J. Pérez-Stable, MD, director of the NIMHD.
Priorities of the new NIMHD initiative include:
• Developing new methods for integrating patient data with community influences that affect population health
• Isolating critical biomarkers that can pinpoint disease progression and drug responses in diverse populations
• Translating genomic discoveries into clinical practices and effective treatments
• Determining barriers that may hinder the implementation of precision medicine in care for populations that experience disparities in care
• Identifying causes that incite different health outcomes in minority populations and populations that experience care disparities
More articles on quality:
Researchers develop portable device to create biologic drugs in the field
EHR go-live does not adversely impact patient safety, new study finds
Nationwide Children’s develops new type of chemo effective in adults, kids
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
